This thrombocytopenia is not mediated by “heparin-induced thrombocytopenia” but via generating platelet-activating antibodies against platelet-factor 4 (PF4), designated as “vaccine-induced immune thrombotic thrombocytopenia (VITT)” [86,87]. Here, PF4 is linked to Thrombocytopenia.